Form 4 TABER ROBERT I For: Jul 01
More News related to PTN
- Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
- *Revised* Analyst Reports for Hemispherx Biopharma Inc., Boots & Coots International Well Control Inc., Palatin Technologies Inc., and Rexahn Pharmaceuticals Inc.
- Palatin Technologies Announces Amendment Expanding AstraZeneca Obesity Collaboration
- Palatin Technologies (PTN) Announces Positive Study Results for PL-3994
- Palatin Technologies (PTN) To Cut 30% of Workforce
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=5765056
Filed on: July 3, 2008
Related Categories
SEC FilingsStocks Mentioned
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
